Trial intelligence / Profile preview

Sertraline and Habit Reversal in Trichotillomania

NCT00118014Phase 4Completed

Sponsor
Massachusetts General Hospital
Start
Jan 2000
Primary completion
Apr 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sertraline in trichotillomania (TTM), sponsored by Massachusetts General Hospital. Started Jan 2000; status: completed.

02

Drugs

sertraline
03

Conditions

trichotillomania (TTM)

Beyond the preview

Go deeper on NCT00118014.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00118014.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call